News & Updates
Filter by Specialty:
OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies
Omalizumab scores in the NIH*-sponsored phase III OUtMATCH** trial, increasing the threshold for an allergic reaction to peanut and other common food allergens in children and adults with multiple food allergies.
OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies
05 Mar 2024High intake of macronutrients ups ADHD risk in children
Children who have lower intakes of vitamins and mineral and higher intakes of macronutrients are more likely to have attention deficit hyperactivity disorder (ADHD), suggests an Egypt study.
High intake of macronutrients ups ADHD risk in children
26 Feb 2024Bacterial codetection tied to better outcomes in ventilated infants with bronchiolitis
Bacterial respiratory tract infection normally occurs in infants requiring early intubation in the emergency department (ED) for viral bronchiolitis, according to a study. However, respiratory bacterial codetection appears to shorten the duration of mechanical ventilation (MV) and length of stay (LOS) of these patients in the intensive care unit (ICU).
Bacterial codetection tied to better outcomes in ventilated infants with bronchiolitis
25 Feb 2024Methylnaltrexone proves safety in paediatric oncology patients with constipation
Subcutaneous methylnaltrexone is safe to use in children with cancer who have opioid-induced constipation, suggest the results of a study. In addition, this agent stimulates bowel movements in more than a third of paediatric patients.